These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 335607)

  • 21. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of media containing chromogenic substrates for the identification and the listing of urinary bacteria].
    Martin C; Orenga S; Doleans F; Denis F
    Pathol Biol (Paris); 1995 Nov; 43(9):749-53. PubMed ID: 8746095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The structure and antibiotic sensitivity of the causative agents of community-acquired infectious diseases of bacterial origin in children].
    Samsygina GA; Dudina TA; Korniushin MA; Ovechkina NV
    Antibiot Khimioter; 2000; 45(3):15-9. PubMed ID: 10768061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). III. Secular changes in susceptibility].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1174-263. PubMed ID: 7474335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of urinary tract infections in burn patients].
    Leseva M; Zozikov B
    Khirurgiia (Sofiia); 1998; 53(6):33-7. PubMed ID: 11247066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections.
    Cai T; Nesi G; Mazzoli S; Meacci F; Lanzafame P; Caciagli P; Mereu L; Tateo S; Malossini G; Selli C; Bartoletti R
    Clin Infect Dis; 2015 Dec; 61(11):1655-61. PubMed ID: 26270684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of cefixime and co-trimoxazole in acute uncomplicated urinary tract infection. A double-blind general practice study.
    Levenstein J; Summerfield PJ; Fourie S; Brink G; Michaelides B; Murray E; Naidoo N
    S Afr Med J; 1986 Oct; 70(8):455-60. PubMed ID: 3535127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Sakai S; Hirose T; Shigeta S; Shiraiwa Y; Miura Y; Ogata M; Tazaki H; Iri H
    Jpn J Antibiot; 1986 Nov; 39(11):3019-93. PubMed ID: 3102809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [High incidence of resistant pathogens in community acquired bacteriuria from patients in the Jerusalem area with lower urinary tract infections].
    Abdul-Ghani MA; Glicberg F; Sahagian H
    Harefuah; 2002 Dec; 141(12):1032-5, 1091, 1090. PubMed ID: 12534199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the antibiotic sensitivities of urinary pathogens, 1971-1989.
    Grüneberg RN
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():3-11. PubMed ID: 2292543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Monitoring of uropathogens and their susceptibility to antibiotics].
    Savitskaia KI; Trapeznikova MF; Nesterova MV; Rusanova EV
    Antibiot Khimioter; 2001; 46(6):12-20. PubMed ID: 11573319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary tract infections in Norway: bacterial etiology and susceptibility. A retrospective study of clinical isolates.
    Grude N; Tveten Y; Kristiansen BE
    Clin Microbiol Infect; 2001 Oct; 7(10):543-7. PubMed ID: 11683794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cinoxacin: effectiveness against experimental pyelonephritis in rats.
    Holmes DH; Ensminger PW; Gordee RS
    Antimicrob Agents Chemother; 1974 Oct; 6(4):432-6. PubMed ID: 4157340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua.
    Matute AJ; Hak E; Schurink CA; McArthur A; Alonso E; Paniagua M; Van Asbeck E; Roskott AM; Froeling F; Rozenberg-Arska M; Hoepelman IM
    Int J Antimicrob Agents; 2004 May; 23(5):506-9. PubMed ID: 15120732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    J Infect; 2014 Sep; 69(3):266-77. PubMed ID: 24780763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative evaluation of norfloxacin and cinoxacin in the therapy of complicated infections of the urinary tract].
    Cristiano P; Morelli G; Simioli F; Iovene MR; Della Vittoria Scarpati M; Manguso L
    Minerva Med; 1989 Apr; 80(4):393-5. PubMed ID: 2657499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial resistance in community-acquired urinary tract infections in Paris in 2015.
    Chervet D; Lortholary O; Zahar JR; Dufougeray A; Pilmis B; Partouche H
    Med Mal Infect; 2018 May; 48(3):188-192. PubMed ID: 29054298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of cinoxacin in urinary tract infections.
    Panwalker AP; Giamarellou H; Jackson GG
    Antimicrob Agents Chemother; 1976 Mar; 9(3):502-5. PubMed ID: 1259405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). I. Susceptibility distribution].
    Kosakai N; Kumamoto Y; Sakai S; Hirose T; Shigeta S; Shiraiwa Y; Miura Y; Ogata M; Tazaki H; Iri H
    Jpn J Antibiot; 1986 Nov; 39(11):2959-3006. PubMed ID: 3102808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.